Do cyclic-AMP agonists inhibit antiphospholipid/beta2-glycoprotein I induced synthesis of human platelet thromboxane A2 in vitro?
Our findings suggest the usefulness of cAMP agonists in the control of thrombosis in some patients with SLE and APS.
We conclude that APG clearly discriminated arms with documented DVT from controls and is a highly accurate means of identifying upper extremity DVT.